濮阳东方妇科技术好(濮阳东方男科收费目录) (今日更新中)

HARARE, Feb. 9 (Xinhua) -- The two-day visit to Zimbabwe by Chinese Foreign Minister Yang Jiechi starting Thursday is an endorsement of relations between the Southern African country and China, local figures told Xinhua.Former Zimbabwean ambassador to China Chris Mutsvangwa said in an interview on Tuesday that Yang's visit will also boost economic relations between the two countries."The visit of a foreign minister is a big banner announcement to say that relations between Zimbabwe and China are reaching for a new level," he said."This is a visit which will mark a new diplomatic high watermark in Zimbabwe's international relations because to get the visit of an important and emerging super-power like China with such economic clout is a big vote of confidence on the part of Zimbabweans who have been pummeled by sanctions" imposed by the West.Yang, who will make the visit at the invitation of Zimbabwean Foreign Minister Simbarashe Mumbengegwi, is scheduled to meet President Robert Mugabe and other senior government officials.Mutsvangwa said the Chinese veto at the United Nations in 2008 was "a landmark diplomatic decision where it basically saved Zimbabwe from punitive sanctions instigated by an irate and sulky former colonial power.""So, now this visit will give an opportunity for Zimbabweans tofinally thank China for this act. But more important, cooperation in the economic field is beginning to gather pace because we have crossed the diplomatic and political travails which have been going on in the last 10 years and come out more united because the Chinese veto also enabled Zimbabweans to find accommodation among themselves and led to the GNU and GPA," Mutsvangwa said.China, together with Russia, vetoed the British initiative for full-scale UN sanctions against Zimbabwe, saying the Southern African Development Community (SADC) and the African Union (AU) should be given a chance to resolve the country's political problems.A SADC-driven initiative led to a Government of National Unity (GNU) following the signing of the Global Political Agreement (GPA) between Mugabe and then rivals Prime Minister Morgan Tsvangirai and Deputy Prime Minister Arthur Mutambara."So there is more national unity now among Zimbabweans. It is an opportune moment for us to tighten our relations with China so that we can explore cooperation in the more rewarding material areas of agriculture, mining, tourism and industrialization."There is clearly a lot of scope for cooperation between Zimbabwe and China so that Zimbabwe can quicken its modernization pace taking advantage of the stellar achievements of the Chinese in the above areas," Mutsvangwa said.He cited areas such as telecommunications, international logistics and the internet as being led by the Chinese.China Tobacco has also been on the fore-front reviving tobacco farming in Zimbabwe for the past five years.Mutsvangwa said shortages in the global cotton sector could spur better trade relations between the two countries and lead to more opportunities for Zimbabwean farmers.

LJUBLJANA, April 12 (Xinhua)-- Slovenian surgeons have successfully developed a new method of breast reconstruction for cancer patients, the Slovenian Press Agency (STA) reported on Tuesday.Surgeons in Ljubljana Central Hospital use a three-dimensional mould to form a new breast from the patient's abdominal fat, and then have the tissue implanted and fixated in the place of the removed breast.The mould making technique, developed by the Ljubljana Faculty of Mechanical Engineering, uses a laser to make an exact imprint of the healthy breast, which is then used to make a mirror-image three-dimensional mould for the reconstruction.That is the first in the world to help woman patients overcome embarrassment of losing their breast after mastectomy, according to the report.Speaking of the effect of the treatment, Uros Ahcan, head of plastic surgery ward in Ljubljana Central Hospital , said that the reconstructed breast is as symmetrical as possible with the healthy breast.The latest breast reconstruction method has an advantage over artificial implants, because a breast reconstructed from adipose tissue grows and shrinks in case of weight gain and weight loss. In addition, the tissue has the same temperature as the rest of the body, the STA quoted Ahcan as saying.The Ljubljana Central Hospital have done eight breast reconstruction operations for cancer patients, all of them were successful, with ten more planned in the coming weeks, the report added.Some 1,200 Slovenian women are reportedly diagnosed with breast cancer annually. About 70 percent of the patients hope to have breast reconstruction after mastectomy.

LOS ANGELES, May 14 (Xinhua) -- Thousands of visitors, many of them children, went to the Jet Propulsion Laboratory (JPL) in Pasadena, California for the annual open house Saturday to experience the excitement in explorations.To many visitors, the open house is a rare opportunity to see the federally funded research and development center and the National Aeronautics and Space Administration (NASA) field center, which is close to the public. JPL is managed by California Institute of Technology.The event, themed "The Excitement in Explorations," provides visitors with the chance to share in the wonders of space through high-definition and 3-D videos, live demonstrations, interactions with scientists and engineers, and a first look at JPL's new Earth Science Center.The Earth Science Center showcases the home planet and JPL's Earth science missions. Since it was the first time open to the public, it attracted many visitors who had to wait for over an hour to get admitted.Visitors first passed by two touchscreens located on opposite walls of the facility that control real-time views of "Eyes on the Earth," an interactive 3-D visualization website. Visitors also had the opportunity to watch a movie in the 3-D theater, which seats up to 40 people.Other Open House highlights include: A chance to see the most unique car in this world before it leaves Earth: The next rover bound for Mars, Mars Science Laboratory/Curiosity, in the "clean room" before it is shipped to Florida for a November 2011 launch.JPL further runs its own "reality TV show" via live-streaming webcam: http://www.ustream.tv/nasajpl.The life-size rover models in a "Mars" test bed is another attraction and a perennial crowd-pleaser. Named the Robo-Dome, it is where visitors could see a pair of 700-pound robots gliding in a high-tech arena under artificial stars.The Robo-Dome is used to simulate complex maneuvers that could be used for future space missions.The year 2011 is an exciting year for JPL's robotic explorers. In the past twelve months, two spacecraft made close encounters of comets. This summer, the Dawn spacecraft will arrive at the giant asteroid Vesta.In 2011, JPL will launch the Aquarius satellite studying Earth' s ocean, the Juno mission to Jupiter, the Gravity Recovery and Interior Laboratory's twin spacecraft to Earth's moon, and JPL's next-generation rover - Mars Science Laboratory's Curiosity.

WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.

来源：资阳报